View Older Stories View More Recent Stories

Nov 3, 2021 03:04PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Nov 2, 2021 05:02PM Form SC 13D/A Repare Therapeutics Inc. Filed by: ORBIMED ADVISORS LLC
Oct 19, 2021 05:24PM Form SC 13D Theseus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Oct 14, 2021 05:01PM Form SC 13G/A Kala Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Sep 29, 2021 04:32PM Form SC 13D/A SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
Sep 22, 2021 05:28PM Form 4 Corvus Pharmaceuticals, For: Sep 20 Filed by: ORBIMED ADVISORS LLC
Sep 22, 2021 05:21PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Sep 14, 2021 06:15AM i2020 Accelerator Announces the Launch of Gwynant Therapeutics and Celyn Therapeutics to Develop Novel Small Molecules for Oncology Targets
Sep 9, 2021 07:00AM iECURE Launches With $50 Million Series A Financing to Develop In Vivo Gene Insertion Approaches for Devastating Diseases
Sep 8, 2021 09:51AM ADARx Raises $75 Million to Advance Growing Pipeline
Sep 3, 2021 04:48PM Form SC 13D/A Aadi Bioscience, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 3, 2021 04:37PM Form SC 13D/A BELLUS Health Inc. Filed by: ORBIMED ADVISORS LLC
Sep 2, 2021 08:28PM Form 4 Repare Therapeutics Inc. For: Aug 31 Filed by: ORBIMED ADVISORS LLC
Aug 31, 2021 04:53PM Form SC 13D/A Acutus Medical, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 30, 2021 06:37PM Form 4 Repare Therapeutics Inc. For: Aug 26 Filed by: ORBIMED ADVISORS LLC
Aug 26, 2021 06:30AM Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders
Aug 25, 2021 08:44PM Form 4 Repare Therapeutics Inc. For: Aug 23 Filed by: ORBIMED ADVISORS LLC
Aug 19, 2021 08:55PM Form 4 Repare Therapeutics Inc. For: Aug 17 Filed by: ORBIMED ADVISORS LLC
Aug 17, 2021 05:59PM Form 4 Xtant Medical Holdings, For: Aug 15 Filed by: ORBIMED ADVISORS LLC
Aug 16, 2021 04:46PM Form SC 13D/A Ikena Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 16, 2021 04:19PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 12, 2021 04:18PM Form SC 13D/A Oric Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 4, 2021 05:22PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 4, 2021 12:00PM XinThera Closes $50M Series B Financing
Aug 2, 2021 07:00AM Zentera Therapeutics Announces Closing of $75 Million Series B Financing
Aug 2, 2021 07:00AM Zentera Therapeutics Announces Closing of $75 Million Series B Financing
Jul 23, 2021 05:31PM Form 4/A IMARA Inc. For: Jul 16 Filed by: ORBIMED ADVISORS LLC
Jul 21, 2021 05:30PM Form 4 Acutus Medical, Inc. For: Jul 19 Filed by: ORBIMED ADVISORS LLC
Jul 16, 2021 04:28PM Form 4 IMARA Inc. For: Jul 16 Filed by: ORBIMED ADVISORS LLC
Jul 14, 2021 05:09PM Form SC 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Jul 14, 2021 06:04AM Form SC 13D/A Acutus Medical, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 6, 2021 04:43PM Form 4 SpringWorks Therapeutics For: Jul 01 Filed by: ORBIMED ADVISORS LLC
Jun 30, 2021 09:02PM Form 4 SpringWorks Therapeutics For: Jun 28 Filed by: ORBIMED ADVISORS LLC
Jun 25, 2021 07:12PM Form 4 SpringWorks Therapeutics For: Jun 23 Filed by: ORBIMED ADVISORS LLC
Jun 23, 2021 03:30AM Leukocare Announces USD 17.5 Million Financing Round to Further Expand US Business and Bioinformatics Activities
Jun 22, 2021 06:02AM Form SC 13D Janux Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 15, 2021 11:32AM Frontera Therapeutics Starts GMP Manufacturing Facility Construction
Jun 14, 2021 05:58PM Form 4 SpringWorks Therapeutics For: Jun 10 Filed by: ORBIMED ADVISORS LLC
Jun 9, 2021 06:27PM Form 4 SpringWorks Therapeutics For: Jun 07 Filed by: ORBIMED ADVISORS LLC
May 17, 2021 04:23PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 11, 2021 07:00AM Xtant Medical Files $150 Million Shelf Registration Statement
Apr 29, 2021 05:18PM Form SC 13G NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Apr 26, 2021 05:21PM Form 4 NeuroPace Inc For: Apr 26 Filed by: ORBIMED ADVISORS LLC
Apr 23, 2021 08:33PM Form 4 NeuroPace Inc For: Apr 21 Filed by: ORBIMED ADVISORS LLC
Apr 22, 2021 06:51PM Sinovac Reports Unaudited Fourth Quarter 2020 Financial Results and Files 2020 Annual Report on Form 20-F
Apr 22, 2021 05:19PM Form 4 SYNLOGIC, INC. For: Apr 20 Filed by: ORBIMED ADVISORS LLC
Apr 22, 2021 05:04PM Form SC 13D/A SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
Apr 22, 2021 05:00AM ITM Raises EUR 90 M (USD 109 M) to Accelerate Precision Oncology Pipeline and Support Ongoing Phase 3 Clinical Program
Apr 20, 2021 05:31PM Form 3 NeuroPace Inc For: Apr 20 Filed by: ORBIMED ADVISORS LLC
Apr 20, 2021 04:38PM Form SC 13G VectivBio Holding AG Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories